Presentations: March 30 - 31, 2022 || 1-on-1 Meetings: March 28 - April 1, 2022
MedInvest Conferences is a leading conference series in healthcare and life sciences. MedInvest conducts conferences four times a year, typically focusing on specific indications: oncology, cardiology, neurology, etc. In addition, MedInvest hosted conferences focusing on specific areas of healthcare: AI, Big Data, Digital Health, Medical Devices. The upcoming conference will focus on drug development and delivery and biotech tools and therapies across multiple indications.
The MedInvest Pharmaceutical and Biotechnology Investor Conference will feature informative panel discussions, keynote talks, corporate presentations, and one-on-one meetings. Global leaders in life sciences will discuss the latest trends in drug discovery, clinical trials, and market opportunity, exploring new frontiers for business and for healthcare in pharma and biotech.
Join life science venture capitalists, family offices, company executives, foundations, academics, government officials, and health institutes for a discussion and networking on developments within the sector. The main objective of the conference is to help early and mid-stage pharmaceutical and biotech companies partner with investors.
Conference series sponsors included the National Foundation for Cancer Research, Nuvisan, Pharpoint Research, Cooley Law Firm, Wilson Sonsini Law Firm, McDermitt, Will & Emery, Perkins Coie Law Firm, Venable law firm, Skipper BioMed, Torreya Partners and Marcum.
150+ Investors. Presenting Companies. Speakers. Panels. Virtual Partnering System. One-On-One Meetings.
All Presenters are Screened.
INVESTORS, GOVERNMENT, ACADEMIA
Screened & Must Be Approved in Advance.
Sponsors Limited by Category
PRIOR MEDINVEST SERIES SPEAKERS
(Across All Topic Areas)